These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 32297435)

  • 1. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
    Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
    Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis.
    Zang Y; Qiu Y; Sun Y; Fan Y
    Qual Life Res; 2024 Jun; 33(6):1455-1468. PubMed ID: 38227073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
    Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
    Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlled Trials.
    Wagner C; Witt JH; Nolte S; van der Poel HG; Aaronson NK; Kolvatzis M; Tian Z; Mendrek M; Liakos N; Gratzke C; Leyh-Bannurah SR
    Eur Urol Focus; 2024 May; 10(3):454-460. PubMed ID: 36863963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Geriatric 8 frailty and health-related quality of life in older patients with cancer (PROGNOSIS-G8): a Danish single-centre, prospective cohort study.
    Ditzel HM; Giger AW; Lund CM; Ditzel HJ; Möller S; Pfeiffer P; Ryg J; Ewertz M; Jørgensen TL
    Lancet Healthy Longev; 2024 Sep; 5(9):100612. PubMed ID: 39217995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.
    van Kleef JJ; Dijksterhuis WPM; van den Boorn HG; Prins M; Verhoeven RHA; Gisbertz SS; Slingerland M; Mohammad NH; Creemers GJ; Neelis KJ; Heisterkamp J; Rosman C; Ruurda JP; Kouwenhoven EA; van de Poll-Franse LV; van Oijen MGH; Sprangers MAG; van Laarhoven HWM;
    Gastric Cancer; 2021 Nov; 24(6):1203-1212. PubMed ID: 34251543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials.
    Ediebah DE; Quinten C; Coens C; Ringash J; Dancey J; Zikos E; Gotay C; Brundage M; Tu D; Flechtner HH; Greimel E; Reeve BB; Taphoorn M; Reijneveld J; Dirven L; Bottomley A;
    Cancer; 2018 Aug; 124(16):3409-3416. PubMed ID: 29905936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
    Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
    Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
    Mol L; Ottevanger PB; Koopman M; Punt CJ
    Eur J Cancer; 2016 Oct; 66():138-43. PubMed ID: 27573427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
    Anker MS; Potthoff SK; Lena A; Porthun J; Hadzibegovic S; Evertz R; Denecke C; Fröhlich AK; Sonntag F; Regitz-Zagrosek V; Rosen SD; Lyon AR; Lüscher TF; Spertus JA; Anker SD; Karakas M; Bullinger L; Keller U; Landmesser U; Butler J; von Haehling S
    Eur J Heart Fail; 2023 Sep; 25(9):1635-1647. PubMed ID: 37369985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
    Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
    Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
    Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
    BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.
    Giesinger JM; Kieffer JM; Fayers PM; Groenvold M; Petersen MA; Scott NW; Sprangers MA; Velikova G; Aaronson NK;
    J Clin Epidemiol; 2016 Jan; 69():79-88. PubMed ID: 26327487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis.
    Mackay TM; Latenstein AEJ; Sprangers MAG; van der Geest LG; Creemers GJ; van Dieren S; de Groot JB; Groot Koerkamp B; de Hingh IH; Homs MYV; de Jong EJM; Molenaar IQ; Patijn GA; van de Poll-Franse LV; van Santvoort HC; de Vos-Geelen J; Wilmink JW; van Eijck CH; Besselink MG; van Laarhoven HWM;
    J Natl Compr Canc Netw; 2020 Oct; 18(10):1354-1363. PubMed ID: 33022643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Movsas B; Moughan J; Sarna L; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Wasserman T; Bruner DW
    J Clin Oncol; 2009 Dec; 27(34):5816-22. PubMed ID: 19858383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.